CENTER FOR DRUGS EVALUATION AND RESEARCH
The mission of FDA’s CDER is to assure that safe and effective drugs are available.
4 main areas of activity:
INTERNATIONAL COUNCIL FOR HARMONISATION Organisation which aim is a formulation of a joint regulatory industry initiative on the international harmonisation of drug regulations. It is composed of representatives from regulatory agencies and industry associations from US, EU and Japan.
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is unique in bringing together the regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of drug registration.